3088b857的个人主页 - 老虎社区

3088b857

暂无个人介绍

IP属地：未知

8关注

0粉丝

0主题

0勋章

2021-07-13

Like

抱歉，原内容已删除

2021-06-22

Oh

抱歉，原内容已删除

2021-06-21

Nice

Orphazyme rose more than 6% in premarket trading

2021-06-21

Ok

抱歉，原内容已删除

2021-06-19

Like

抱歉，原内容已删除

2021-06-18

[Doubt]

抱歉，原内容已删除

2021-06-18

[Lovely]

抱歉，原内容已删除

2021-06-18

Tell me your opinion about this news...

抱歉，原内容已删除

2021-06-18

[Strong]

抱歉，原内容已删除

2021-06-18

[Smile] [Smile]

抱歉，原内容已删除

2021-06-17

[Smile]

Breaking ranks, Norway signals 4 rate hikes by mid-2022

2021-06-17

👍🏻👍🏻

Toplines Before US Market Open on Thursday

2021-06-17

Hmm

Stocks are flat after post-Fed decision sell-off

2021-06-16

Ohh

抱歉，原内容已删除

2021-06-16

👍🏻

抱歉，原内容已删除

2021-06-16

Ohh

抱歉，原内容已删除

2021-06-16

Oh

抱歉，原内容已删除

2021-06-16

Nice

抱歉，原内容已删除

2021-06-16

Yes

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3566691395182663","uuid":"3566691395182663","gmtCreate":1603597371989,"gmtModify":1623853851282,"name":"3088b857","pinyin":"charlotte26","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":8,"tweetSize":19,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.11","exceedPercentage":"60.56%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":142822709,"gmtCreate":1626141928501,"gmtModify":1633929709721,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/142822709","repostId":"1175534160","repostType":4,"isVote":1,"tweetType":1,"viewCount":684,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120449218,"gmtCreate":1624334394634,"gmtModify":1634007615116,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/120449218","repostId":"1191349655","repostType":4,"isVote":1,"tweetType":1,"viewCount":542,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167677108,"gmtCreate":1624268018504,"gmtModify":1634008661767,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/167677108","repostId":"1184501396","repostType":4,"repost":{"id":"1184501396","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624267024,"share":"https://www.laohu8.com/m/news/1184501396?lang=&edition=full","pubTime":"2021-06-21 17:17","market":"us","language":"en","title":"Orphazyme rose more than 6% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1184501396","media":"Tiger Newspress","summary":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a c","content":"<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p>\n<p><img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p>\n<p><b>So what</b></p>\n<p>The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p>\n<p>Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p>\n<p>Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p>\n<p><b>Now what</b></p>\n<p>According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p>\n<p>Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p>\n<p>Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme rose more than 6% in premarket trading </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme rose more than 6% in premarket trading \n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-21 17:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p>\n<p><img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p>\n<p><b>So what</b></p>\n<p>The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p>\n<p>Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p>\n<p>Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p>\n<p><b>Now what</b></p>\n<p>According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p>\n<p>Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p>\n<p>Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p>\n<p></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184501396","content_text":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last Friday.\nSo what\nThe FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.\nInstead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.\nMany institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.\nNow what\nAccording to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.\nSome shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.\nDespite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.","news_type":1},"isVote":1,"tweetType":1,"viewCount":565,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167674785,"gmtCreate":1624267997047,"gmtModify":1634008661990,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/167674785","repostId":"1154249454","repostType":4,"isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":165091616,"gmtCreate":1624079232035,"gmtModify":1634010936496,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165091616","repostId":"2144034771","repostType":4,"isVote":1,"tweetType":1,"viewCount":641,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166480199,"gmtCreate":1624022514011,"gmtModify":1634023995857,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"[Doubt]&nbsp;","listText":"[Doubt]&nbsp;","text":"[Doubt]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/166480199","repostId":"1164089282","repostType":4,"isVote":1,"tweetType":1,"viewCount":572,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166417840,"gmtCreate":1624022494880,"gmtModify":1634023996561,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"[Lovely]&nbsp;","listText":"[Lovely]&nbsp;","text":"[Lovely]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/166417840","repostId":"1181667218","repostType":4,"isVote":1,"tweetType":1,"viewCount":338,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168462546,"gmtCreate":1623981233985,"gmtModify":1634024788926,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168462546","repostId":"2144374909","repostType":4,"isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168462335,"gmtCreate":1623981219127,"gmtModify":1634024789411,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"[Strong]&nbsp;","listText":"[Strong]&nbsp;","text":"[Strong]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168462335","repostId":"2144490227","repostType":4,"isVote":1,"tweetType":1,"viewCount":343,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168528788,"gmtCreate":1623979040844,"gmtModify":1634024864907,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"[Smile]&nbsp;[Smile]&nbsp;","listText":"[Smile]&nbsp;[Smile]&nbsp;","text":"[Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168528788","repostId":"2144742524","repostType":4,"isVote":1,"tweetType":1,"viewCount":482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161449749,"gmtCreate":1623939014481,"gmtModify":1634025585276,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/161449749","repostId":"1160003162","repostType":4,"repost":{"id":"1160003162","kind":"news","pubTimestamp":1623929570,"share":"https://www.laohu8.com/m/news/1160003162?lang=&edition=full","pubTime":"2021-06-17 19:32","market":"us","language":"en","title":"Breaking ranks, Norway signals 4 rate hikes by mid-2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1160003162","media":"Reuters","summary":"* Norges Bank holds base rate at 0%\n* But govenor signals hikes in each of next four quarters\n* Like","content":"<p>* Norges Bank holds base rate at 0%</p>\n<p>* But govenor signals hikes in each of next four quarters</p>\n<p>* Likely to be first G10 central bank to hike rates</p>\n<p>* By contrast, no change to ultra-loose outlook for SNB</p>\n<p>* U.S. Fed opened door to post-COVID policy era on Weds (Releads with news conference)</p>\n<p>OSLO, June 17 (Reuters) - Norway’s central bank said on Thursday it expected to raise interest rates four times by mid-2022 as the economy shakes off the effects of COVID-19, breaking ranks with the still ultra-loose policy outlook of counterparts in other developed nations.</p>\n<p>A day after the Federal Reserve signalled U.S rates would probably rise from 2023 rather than 2024, Norges Bank’s monetary policy committee kept its key rate unchanged at a record low 0.0% but said a hike was likely in September and others soon after.</p>\n<p>“Given the rate path we see now, rates will be raised by 0.25% in (each of) the next four quarters,” Governor Oeystein Olsen told a news conference.</p>\n<p>Announced delays in vaccine deliveries to Norway in the third quarter did not “shift the big picture” on the economic recovery, he added in an interview with Reuters.</p>\n<p>With many of the world’s central banks laying the groundwork for a post-pandemic transition to life with less stimulus, the Fed on Wednesday also opened talks on how to end its crisis-era bond-buying.</p>\n<p>Norges Bank looks set to be be the first of the G10 group of developed economies’ central banks to raise the cost of borrowing, however, having previously signalled a hike this year.</p>\n<p>Economists polled by Reuters had been almost evenly split over whether it that would happen in September or December.</p>\n<p>But few had predicted two hikes by year-end.</p>\n<p>In stark contrast, the Swiss National Bank on Thursday signalled monetary policy would stay ultra-loose for the foreseeable future, saying projected higher inflation was no reason to change course and citing a highly valued Swiss franc.</p>\n<p>REAL ESTATE BOOM</p>\n<p>Norway’s currency, the crown, firmed to trade at 10.12 against the euro from 10.15 just before Norges Bank’s policy announcement. It then fell back to 10.21.</p>\n<p>“In the light of today’s hawkish message from Norges Bank, we will revise our policy rate forecast upward,” economists at Handelsbanken wrote.</p>\n<p>The central bank said the monetary policy committee’s revised forecasts implied a slightly faster series of rate rises towards 2024 than in previous predictions issued in March.</p>\n<p>Part of the reason behind the accelerated timetable is a rapidly recovering economy.</p>\n<p>Norges Bank on Thursday held its forecast for GDP growth of 3.8% in 2021, but raised its prediction for next year to 4.1% from 3.4%.</p>\n<p>Another factor is house price inflation, which has gathered pace since Norway cut rates three times last year to combat the impact of COVID-19, contributing to a property boom as borrowers took advantage of cheap credit.</p>\n<p>While core inflation was expected to ease to 1.7% this year from 3.0% last year, below the central bank’s 2% goal, it forecast house prices would rise by 9.2% in 2021 after expanding by 4.5% in 2020.</p>\n<p>In a related statement on Thursday, Norway’s finance ministry said it would force banks to hold more supplementary buffer capital, 1.5% of its balance sheet instead of 1%, boosting the system’s solidity while making less capital available for lending.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Breaking ranks, Norway signals 4 rate hikes by mid-2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBreaking ranks, Norway signals 4 rate hikes by mid-2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/norway-economy-rates/update-4-breaking-ranks-norway-signals-4-rate-hikes-by-mid-2022-idUSL5N2NZ1VI><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>* Norges Bank holds base rate at 0%\n* But govenor signals hikes in each of next four quarters\n* Likely to be first G10 central bank to hike rates\n* By contrast, no change to ultra-loose outlook for ...</p>\n\n<a href=\"https://www.reuters.com/article/norway-economy-rates/update-4-breaking-ranks-norway-signals-4-rate-hikes-by-mid-2022-idUSL5N2NZ1VI\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯"},"source_url":"https://www.reuters.com/article/norway-economy-rates/update-4-breaking-ranks-norway-signals-4-rate-hikes-by-mid-2022-idUSL5N2NZ1VI","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160003162","content_text":"* Norges Bank holds base rate at 0%\n* But govenor signals hikes in each of next four quarters\n* Likely to be first G10 central bank to hike rates\n* By contrast, no change to ultra-loose outlook for SNB\n* U.S. Fed opened door to post-COVID policy era on Weds (Releads with news conference)\nOSLO, June 17 (Reuters) - Norway’s central bank said on Thursday it expected to raise interest rates four times by mid-2022 as the economy shakes off the effects of COVID-19, breaking ranks with the still ultra-loose policy outlook of counterparts in other developed nations.\nA day after the Federal Reserve signalled U.S rates would probably rise from 2023 rather than 2024, Norges Bank’s monetary policy committee kept its key rate unchanged at a record low 0.0% but said a hike was likely in September and others soon after.\n“Given the rate path we see now, rates will be raised by 0.25% in (each of) the next four quarters,” Governor Oeystein Olsen told a news conference.\nAnnounced delays in vaccine deliveries to Norway in the third quarter did not “shift the big picture” on the economic recovery, he added in an interview with Reuters.\nWith many of the world’s central banks laying the groundwork for a post-pandemic transition to life with less stimulus, the Fed on Wednesday also opened talks on how to end its crisis-era bond-buying.\nNorges Bank looks set to be be the first of the G10 group of developed economies’ central banks to raise the cost of borrowing, however, having previously signalled a hike this year.\nEconomists polled by Reuters had been almost evenly split over whether it that would happen in September or December.\nBut few had predicted two hikes by year-end.\nIn stark contrast, the Swiss National Bank on Thursday signalled monetary policy would stay ultra-loose for the foreseeable future, saying projected higher inflation was no reason to change course and citing a highly valued Swiss franc.\nREAL ESTATE BOOM\nNorway’s currency, the crown, firmed to trade at 10.12 against the euro from 10.15 just before Norges Bank’s policy announcement. It then fell back to 10.21.\n“In the light of today’s hawkish message from Norges Bank, we will revise our policy rate forecast upward,” economists at Handelsbanken wrote.\nThe central bank said the monetary policy committee’s revised forecasts implied a slightly faster series of rate rises towards 2024 than in previous predictions issued in March.\nPart of the reason behind the accelerated timetable is a rapidly recovering economy.\nNorges Bank on Thursday held its forecast for GDP growth of 3.8% in 2021, but raised its prediction for next year to 4.1% from 3.4%.\nAnother factor is house price inflation, which has gathered pace since Norway cut rates three times last year to combat the impact of COVID-19, contributing to a property boom as borrowers took advantage of cheap credit.\nWhile core inflation was expected to ease to 1.7% this year from 3.0% last year, below the central bank’s 2% goal, it forecast house prices would rise by 9.2% in 2021 after expanding by 4.5% in 2020.\nIn a related statement on Thursday, Norway’s finance ministry said it would force banks to hold more supplementary buffer capital, 1.5% of its balance sheet instead of 1%, boosting the system’s solidity while making less capital available for lending.","news_type":1},"isVote":1,"tweetType":1,"viewCount":261,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161420802,"gmtCreate":1623938588306,"gmtModify":1634025600789,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"👍🏻👍🏻","listText":"👍🏻👍🏻","text":"👍🏻👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/161420802","repostId":"1185082331","repostType":4,"repost":{"id":"1185082331","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623931553,"share":"https://www.laohu8.com/m/news/1185082331?lang=&edition=full","pubTime":"2021-06-17 20:05","market":"us","language":"en","title":"Toplines Before US Market Open on Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=1185082331","media":"Tiger Newspress","summary":"Technology stocks were set to lead Wall Street lower on Thursday after the Federal Reserve signaled ","content":"<p>Technology stocks were set to lead Wall Street lower on Thursday after the Federal Reserve signaled it could start tapering its massive stimulus earlier than expected, piling pressure on a sector that is seen as vulnerable to higher interest rates.</p>\n<p>At 8:05 a.m. ET, Dow E-minis were down 61 points, or 0.18%, S&amp;P 500 E-minis were down 9.5 points, or 0.23% and Nasdaq 100 E-minis fell 52.75 points, or 0.38%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5c87220b14c23fa1ef2d424bd7883caf\" tg-width=\"584\" tg-height=\"215\"><span>*Source From Tiger Trade, EST 08:05</span></p>\n<p>Powell said progress toward the Fed's dual employment and inflation goals were happening somewhat faster than expected. Central bankers raised their GDP expectations for this year to 7% from 6.5% previously. </p>\n<p>Their unemployment rate estimate remained unchanged at 4.5%. In further evidence that the resumption of business activity has helped get people back to work, the government's latest initial jobless claims total is expected to drop to a new pandemic low of 360,000 for last week. </p>\n<p>The report is issued at 8:30 a.m. ET Thursday. Two weeks ago, new filings for unemployment benefits went below 400,000 for the first time since March 2020.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>CureVac(CVAC)</b> – CureVac shares plunged 46.2% in the premarket after the German drugmaker reported disappointing results from a study of its experimental Covid-19 vaccine. The treatment was 47% effective in a clinical trial, compared to more than 90% for other mRNA-based vaccines fromModerna(MRNA) andPfizer(PFE).</p>\n<p><b>Novavax(NVAX),BioNTech(BNTX)</b> – On the heels of the CureVac news, Novavax added 3.4% in the premarket while BioNTech rose 2.6%. BioNTech's Covid vaccine – developed in partnership with Pfizer – is already approved for use in the US, while Novavax reported 90% efficacy for its vaccine in a recent study.</p>\n<p><b>The Honest Company(HNST)</b> – The household products maker reported a wider-than-expected loss in its first quarter as a public company, although revenue was better than analysts had anticipated. Sales got a boost from pandemic-induced demand for sanitizing products. The stock tumbled 8.3% in premarket trading.</p>\n<p><b>Tenet Healthcare(THC)</b> – The hospital operator's shares jumped 3.5% in the premarket, after it announced the sale of five hospitals and associated physician practices in Florida to Steward Health Care for about $1.1 billion.</p>\n<p><b>Lennar(LEN)</b> – Lennar earned $2.65 per share for its latest quarter, beating the $2.36 a share consensus estimate. Revenue topped forecasts as well. The home builder is dealing with higher input costs and a labor shortage, but the lack of homes for sale in the U.S. helped push prices higher and expand Lennar's profit margins significantly over a year earlier.</p>\n<p><b>Dell Technologies(DELL)</b> – Dell was chosen byDish Network(DISH) to build key parts of the 5G network the satellite TV operator is building in the United States. Dish will launch 5G service in Las Vegas later this year and plans to cover 70% of the U.S. with its network by mid-2023.</p>\n<p><b>Fisker(FSR)</b> – Fisker shares added 2.8% in the premarket after the electric vehicle maker signed a long-term manufacturing agreement withMagna International(MGA). Magna will build the Fisker Ocean electric SUV starting in November 2022.</p>\n<p><b>Aon(AON)</b>,Willis Towers Watson(WLTW) – The U.S. Justice Department sued to block insurance company Aon's deal to buy consulting firm Willis Towers Watson for $35 billion. The department said the combinationcould eliminate competitionin several different markets. Aon and Willis Towers said the move showed a lack of understanding of their businesses, clients and the markets in which they operate.</p>\n<p><b>Akamai Technologies(AKAM)</b> – A variety of financial institutions, governments and airlines experienced brief website outages early Thursday. Some of the outages were linked to a failure at web services company Akamai Technologies, according to people familiar with the matter who spoke to Bloomberg. Akamai said it was aware of the issue and was working to restore service as soon as possible. Shares fell 1.5% in premarket trading.</p>\n<p><b>O'Reilly Automotive(ORLY)</b> – The auto parts retailer struck a new $1.8 billion revolving credit agreement with a group of banks led byJPMorgan Chase(JPM).</p>\n<p><b>Jack In The Box(JACK)</b> – The restaurant chain was rated \"outperform\" in new coverage at RBC Capital, which noted the stock's discounted valuation compared to its peers as well as upbeat prospects for new restaurant growth.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-17 20:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Technology stocks were set to lead Wall Street lower on Thursday after the Federal Reserve signaled it could start tapering its massive stimulus earlier than expected, piling pressure on a sector that is seen as vulnerable to higher interest rates.</p>\n<p>At 8:05 a.m. ET, Dow E-minis were down 61 points, or 0.18%, S&amp;P 500 E-minis were down 9.5 points, or 0.23% and Nasdaq 100 E-minis fell 52.75 points, or 0.38%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5c87220b14c23fa1ef2d424bd7883caf\" tg-width=\"584\" tg-height=\"215\"><span>*Source From Tiger Trade, EST 08:05</span></p>\n<p>Powell said progress toward the Fed's dual employment and inflation goals were happening somewhat faster than expected. Central bankers raised their GDP expectations for this year to 7% from 6.5% previously. </p>\n<p>Their unemployment rate estimate remained unchanged at 4.5%. In further evidence that the resumption of business activity has helped get people back to work, the government's latest initial jobless claims total is expected to drop to a new pandemic low of 360,000 for last week. </p>\n<p>The report is issued at 8:30 a.m. ET Thursday. Two weeks ago, new filings for unemployment benefits went below 400,000 for the first time since March 2020.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>CureVac(CVAC)</b> – CureVac shares plunged 46.2% in the premarket after the German drugmaker reported disappointing results from a study of its experimental Covid-19 vaccine. The treatment was 47% effective in a clinical trial, compared to more than 90% for other mRNA-based vaccines fromModerna(MRNA) andPfizer(PFE).</p>\n<p><b>Novavax(NVAX),BioNTech(BNTX)</b> – On the heels of the CureVac news, Novavax added 3.4% in the premarket while BioNTech rose 2.6%. BioNTech's Covid vaccine – developed in partnership with Pfizer – is already approved for use in the US, while Novavax reported 90% efficacy for its vaccine in a recent study.</p>\n<p><b>The Honest Company(HNST)</b> – The household products maker reported a wider-than-expected loss in its first quarter as a public company, although revenue was better than analysts had anticipated. Sales got a boost from pandemic-induced demand for sanitizing products. The stock tumbled 8.3% in premarket trading.</p>\n<p><b>Tenet Healthcare(THC)</b> – The hospital operator's shares jumped 3.5% in the premarket, after it announced the sale of five hospitals and associated physician practices in Florida to Steward Health Care for about $1.1 billion.</p>\n<p><b>Lennar(LEN)</b> – Lennar earned $2.65 per share for its latest quarter, beating the $2.36 a share consensus estimate. Revenue topped forecasts as well. The home builder is dealing with higher input costs and a labor shortage, but the lack of homes for sale in the U.S. helped push prices higher and expand Lennar's profit margins significantly over a year earlier.</p>\n<p><b>Dell Technologies(DELL)</b> – Dell was chosen byDish Network(DISH) to build key parts of the 5G network the satellite TV operator is building in the United States. Dish will launch 5G service in Las Vegas later this year and plans to cover 70% of the U.S. with its network by mid-2023.</p>\n<p><b>Fisker(FSR)</b> – Fisker shares added 2.8% in the premarket after the electric vehicle maker signed a long-term manufacturing agreement withMagna International(MGA). Magna will build the Fisker Ocean electric SUV starting in November 2022.</p>\n<p><b>Aon(AON)</b>,Willis Towers Watson(WLTW) – The U.S. Justice Department sued to block insurance company Aon's deal to buy consulting firm Willis Towers Watson for $35 billion. The department said the combinationcould eliminate competitionin several different markets. Aon and Willis Towers said the move showed a lack of understanding of their businesses, clients and the markets in which they operate.</p>\n<p><b>Akamai Technologies(AKAM)</b> – A variety of financial institutions, governments and airlines experienced brief website outages early Thursday. Some of the outages were linked to a failure at web services company Akamai Technologies, according to people familiar with the matter who spoke to Bloomberg. Akamai said it was aware of the issue and was working to restore service as soon as possible. Shares fell 1.5% in premarket trading.</p>\n<p><b>O'Reilly Automotive(ORLY)</b> – The auto parts retailer struck a new $1.8 billion revolving credit agreement with a group of banks led byJPMorgan Chase(JPM).</p>\n<p><b>Jack In The Box(JACK)</b> – The restaurant chain was rated \"outperform\" in new coverage at RBC Capital, which noted the stock's discounted valuation compared to its peers as well as upbeat prospects for new restaurant growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185082331","content_text":"Technology stocks were set to lead Wall Street lower on Thursday after the Federal Reserve signaled it could start tapering its massive stimulus earlier than expected, piling pressure on a sector that is seen as vulnerable to higher interest rates.\nAt 8:05 a.m. ET, Dow E-minis were down 61 points, or 0.18%, S&P 500 E-minis were down 9.5 points, or 0.23% and Nasdaq 100 E-minis fell 52.75 points, or 0.38%.\n*Source From Tiger Trade, EST 08:05\nPowell said progress toward the Fed's dual employment and inflation goals were happening somewhat faster than expected. Central bankers raised their GDP expectations for this year to 7% from 6.5% previously. \nTheir unemployment rate estimate remained unchanged at 4.5%. In further evidence that the resumption of business activity has helped get people back to work, the government's latest initial jobless claims total is expected to drop to a new pandemic low of 360,000 for last week. \nThe report is issued at 8:30 a.m. ET Thursday. Two weeks ago, new filings for unemployment benefits went below 400,000 for the first time since March 2020.\nStocks making the biggest moves in the premarket:\nCureVac(CVAC) – CureVac shares plunged 46.2% in the premarket after the German drugmaker reported disappointing results from a study of its experimental Covid-19 vaccine. The treatment was 47% effective in a clinical trial, compared to more than 90% for other mRNA-based vaccines fromModerna(MRNA) andPfizer(PFE).\nNovavax(NVAX),BioNTech(BNTX) – On the heels of the CureVac news, Novavax added 3.4% in the premarket while BioNTech rose 2.6%. BioNTech's Covid vaccine – developed in partnership with Pfizer – is already approved for use in the US, while Novavax reported 90% efficacy for its vaccine in a recent study.\nThe Honest Company(HNST) – The household products maker reported a wider-than-expected loss in its first quarter as a public company, although revenue was better than analysts had anticipated. Sales got a boost from pandemic-induced demand for sanitizing products. The stock tumbled 8.3% in premarket trading.\nTenet Healthcare(THC) – The hospital operator's shares jumped 3.5% in the premarket, after it announced the sale of five hospitals and associated physician practices in Florida to Steward Health Care for about $1.1 billion.\nLennar(LEN) – Lennar earned $2.65 per share for its latest quarter, beating the $2.36 a share consensus estimate. Revenue topped forecasts as well. The home builder is dealing with higher input costs and a labor shortage, but the lack of homes for sale in the U.S. helped push prices higher and expand Lennar's profit margins significantly over a year earlier.\nDell Technologies(DELL) – Dell was chosen byDish Network(DISH) to build key parts of the 5G network the satellite TV operator is building in the United States. Dish will launch 5G service in Las Vegas later this year and plans to cover 70% of the U.S. with its network by mid-2023.\nFisker(FSR) – Fisker shares added 2.8% in the premarket after the electric vehicle maker signed a long-term manufacturing agreement withMagna International(MGA). Magna will build the Fisker Ocean electric SUV starting in November 2022.\nAon(AON),Willis Towers Watson(WLTW) – The U.S. Justice Department sued to block insurance company Aon's deal to buy consulting firm Willis Towers Watson for $35 billion. The department said the combinationcould eliminate competitionin several different markets. Aon and Willis Towers said the move showed a lack of understanding of their businesses, clients and the markets in which they operate.\nAkamai Technologies(AKAM) – A variety of financial institutions, governments and airlines experienced brief website outages early Thursday. Some of the outages were linked to a failure at web services company Akamai Technologies, according to people familiar with the matter who spoke to Bloomberg. Akamai said it was aware of the issue and was working to restore service as soon as possible. Shares fell 1.5% in premarket trading.\nO'Reilly Automotive(ORLY) – The auto parts retailer struck a new $1.8 billion revolving credit agreement with a group of banks led byJPMorgan Chase(JPM).\nJack In The Box(JACK) – The restaurant chain was rated \"outperform\" in new coverage at RBC Capital, which noted the stock's discounted valuation compared to its peers as well as upbeat prospects for new restaurant growth.","news_type":1},"isVote":1,"tweetType":1,"viewCount":141,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161462685,"gmtCreate":1623938527347,"gmtModify":1634025603966,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/161462685","repostId":"1114861992","repostType":4,"repost":{"id":"1114861992","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623936627,"share":"https://www.laohu8.com/m/news/1114861992?lang=&edition=full","pubTime":"2021-06-17 21:30","market":"us","language":"en","title":"Stocks are flat after post-Fed decision sell-off","url":"https://stock-news.laohu8.com/highlight/detail?id=1114861992","media":"Tiger Newspress","summary":"Stocks were flat on Thursday, a day after the Federal Reserve's rate outlook sparked a sell-off.\nThe","content":"<p>Stocks were flat on Thursday, a day after the Federal Reserve's rate outlook sparked a sell-off.</p>\n<p>The Dow Jones Industrial Average dropped 5 points. The S&amp;P 500 was flat and Nasdaq Composite fell 0.15%.</p>\n<p>The closely-watch Federal Reserve meeting Wednesday spurred a sell-off in equities after the central bankmoved up its timeline for rate hikes, seeing two increases in 2023. The Fed also hiked its inflation hitting 3.4% this year, a percentage point higher than the FOMC's forecast in March.</p>\n<p>Materials stocks were set to drop on Thursday as higher rates may further take the air out of a big commodities rally in 2021. China isalso cracking down on the commodities surgeto ease inflation fears.Freeport-McMoRanled materials stocks lower in premarket trading, down 2%. Copper futures were off by 2%.</p>\n<p>Wells FargoandCitigroupwere higher in premarket trading on hopes higher rates will boost profits for banks. Meanwhile, some once-hot tech stocks were lower in premarket trading withZoom VideoandTesladown by about 1%.</p>\n<p>Hedge fund legend&nbsp;David Tepper&nbsp;told CNBC's Scott Wapnerthat the Fed did a good job on Wednesday and that \"the stock market is still fine for now,\" Tepper said. The S&amp;P 500 is less than 1% from an all-time high.</p>\n<p>On Wednesday, the Dow lost about 265 points and the S&amp;P 500 edged 0.5% lower. The Nasdaq Composite dipped 0.2%.</p>\n<p>Markets rallied off their intraday lows Wednesday after Fed Chair Jerome Powell said projections for future rate increases should be \"taken with a big grain of salt\" and reiterated that he believes that inflation is transitory. Powell also did not issue guidance on when the central bank will begin tapering its bond-buying program.</p>\n<p>\"You can think of this meeting that we had as the 'talking about talking about' meeting, if you'd like,\" Powell said when asked about tapering. \"I now suggest that we retire that term, which has served its purpose.\"</p>\n<p>The Fed chair said the central bank will continue to monitor the economic recovery and will provide \"advanced notice\" before announcing any updates regarding tapering.</p>\n<p>The Labor Department reported that initial jobless claimsrose last week to 412,000, an improvement from the previous week's 375,000, but above Dow Jones expectations of 360,000.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks are flat after post-Fed decision sell-off</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks are flat after post-Fed decision sell-off\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-17 21:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stocks were flat on Thursday, a day after the Federal Reserve's rate outlook sparked a sell-off.</p>\n<p>The Dow Jones Industrial Average dropped 5 points. The S&amp;P 500 was flat and Nasdaq Composite fell 0.15%.</p>\n<p>The closely-watch Federal Reserve meeting Wednesday spurred a sell-off in equities after the central bankmoved up its timeline for rate hikes, seeing two increases in 2023. The Fed also hiked its inflation hitting 3.4% this year, a percentage point higher than the FOMC's forecast in March.</p>\n<p>Materials stocks were set to drop on Thursday as higher rates may further take the air out of a big commodities rally in 2021. China isalso cracking down on the commodities surgeto ease inflation fears.Freeport-McMoRanled materials stocks lower in premarket trading, down 2%. Copper futures were off by 2%.</p>\n<p>Wells FargoandCitigroupwere higher in premarket trading on hopes higher rates will boost profits for banks. Meanwhile, some once-hot tech stocks were lower in premarket trading withZoom VideoandTesladown by about 1%.</p>\n<p>Hedge fund legend&nbsp;David Tepper&nbsp;told CNBC's Scott Wapnerthat the Fed did a good job on Wednesday and that \"the stock market is still fine for now,\" Tepper said. The S&amp;P 500 is less than 1% from an all-time high.</p>\n<p>On Wednesday, the Dow lost about 265 points and the S&amp;P 500 edged 0.5% lower. The Nasdaq Composite dipped 0.2%.</p>\n<p>Markets rallied off their intraday lows Wednesday after Fed Chair Jerome Powell said projections for future rate increases should be \"taken with a big grain of salt\" and reiterated that he believes that inflation is transitory. Powell also did not issue guidance on when the central bank will begin tapering its bond-buying program.</p>\n<p>\"You can think of this meeting that we had as the 'talking about talking about' meeting, if you'd like,\" Powell said when asked about tapering. \"I now suggest that we retire that term, which has served its purpose.\"</p>\n<p>The Fed chair said the central bank will continue to monitor the economic recovery and will provide \"advanced notice\" before announcing any updates regarding tapering.</p>\n<p>The Labor Department reported that initial jobless claimsrose last week to 412,000, an improvement from the previous week's 375,000, but above Dow Jones expectations of 360,000.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114861992","content_text":"Stocks were flat on Thursday, a day after the Federal Reserve's rate outlook sparked a sell-off.\nThe Dow Jones Industrial Average dropped 5 points. The S&P 500 was flat and Nasdaq Composite fell 0.15%.\nThe closely-watch Federal Reserve meeting Wednesday spurred a sell-off in equities after the central bankmoved up its timeline for rate hikes, seeing two increases in 2023. The Fed also hiked its inflation hitting 3.4% this year, a percentage point higher than the FOMC's forecast in March.\nMaterials stocks were set to drop on Thursday as higher rates may further take the air out of a big commodities rally in 2021. China isalso cracking down on the commodities surgeto ease inflation fears.Freeport-McMoRanled materials stocks lower in premarket trading, down 2%. Copper futures were off by 2%.\nWells FargoandCitigroupwere higher in premarket trading on hopes higher rates will boost profits for banks. Meanwhile, some once-hot tech stocks were lower in premarket trading withZoom VideoandTesladown by about 1%.\nHedge fund legend David Tepper told CNBC's Scott Wapnerthat the Fed did a good job on Wednesday and that \"the stock market is still fine for now,\" Tepper said. The S&P 500 is less than 1% from an all-time high.\nOn Wednesday, the Dow lost about 265 points and the S&P 500 edged 0.5% lower. The Nasdaq Composite dipped 0.2%.\nMarkets rallied off their intraday lows Wednesday after Fed Chair Jerome Powell said projections for future rate increases should be \"taken with a big grain of salt\" and reiterated that he believes that inflation is transitory. Powell also did not issue guidance on when the central bank will begin tapering its bond-buying program.\n\"You can think of this meeting that we had as the 'talking about talking about' meeting, if you'd like,\" Powell said when asked about tapering. \"I now suggest that we retire that term, which has served its purpose.\"\nThe Fed chair said the central bank will continue to monitor the economic recovery and will provide \"advanced notice\" before announcing any updates regarding tapering.\nThe Labor Department reported that initial jobless claimsrose last week to 412,000, an improvement from the previous week's 375,000, but above Dow Jones expectations of 360,000.","news_type":1},"isVote":1,"tweetType":1,"viewCount":174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163078207,"gmtCreate":1623854787509,"gmtModify":1634026991388,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"Ohh","listText":"Ohh","text":"Ohh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163078207","repostId":"2143912677","repostType":4,"isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163044072,"gmtCreate":1623854642196,"gmtModify":1634026996227,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"👍🏻","listText":"👍🏻","text":"👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163044072","repostId":"1100499327","repostType":4,"isVote":1,"tweetType":1,"viewCount":89,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163046740,"gmtCreate":1623854582980,"gmtModify":1634026997643,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"Ohh","listText":"Ohh","text":"Ohh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163046740","repostId":"2143779143","repostType":4,"isVote":1,"tweetType":1,"viewCount":203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163041528,"gmtCreate":1623854535764,"gmtModify":1634026999082,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163041528","repostId":"2143791791","repostType":4,"isVote":1,"tweetType":1,"viewCount":105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163057679,"gmtCreate":1623854484891,"gmtModify":1634027001652,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163057679","repostId":"2143179907","repostType":4,"isVote":1,"tweetType":1,"viewCount":122,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163054537,"gmtCreate":1623854468429,"gmtModify":1634027002481,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163054537","repostId":"1175265723","repostType":4,"isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":167674785,"gmtCreate":1624267997047,"gmtModify":1634008661990,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/167674785","repostId":"1154249454","repostType":4,"isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166417840,"gmtCreate":1624022494880,"gmtModify":1634023996561,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"[Lovely]&nbsp;","listText":"[Lovely]&nbsp;","text":"[Lovely]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/166417840","repostId":"1181667218","repostType":4,"isVote":1,"tweetType":1,"viewCount":338,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161420802,"gmtCreate":1623938588306,"gmtModify":1634025600789,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"👍🏻👍🏻","listText":"👍🏻👍🏻","text":"👍🏻👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/161420802","repostId":"1185082331","repostType":4,"repost":{"id":"1185082331","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623931553,"share":"https://www.laohu8.com/m/news/1185082331?lang=&edition=full","pubTime":"2021-06-17 20:05","market":"us","language":"en","title":"Toplines Before US Market Open on Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=1185082331","media":"Tiger Newspress","summary":"Technology stocks were set to lead Wall Street lower on Thursday after the Federal Reserve signaled ","content":"<p>Technology stocks were set to lead Wall Street lower on Thursday after the Federal Reserve signaled it could start tapering its massive stimulus earlier than expected, piling pressure on a sector that is seen as vulnerable to higher interest rates.</p>\n<p>At 8:05 a.m. ET, Dow E-minis were down 61 points, or 0.18%, S&amp;P 500 E-minis were down 9.5 points, or 0.23% and Nasdaq 100 E-minis fell 52.75 points, or 0.38%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5c87220b14c23fa1ef2d424bd7883caf\" tg-width=\"584\" tg-height=\"215\"><span>*Source From Tiger Trade, EST 08:05</span></p>\n<p>Powell said progress toward the Fed's dual employment and inflation goals were happening somewhat faster than expected. Central bankers raised their GDP expectations for this year to 7% from 6.5% previously. </p>\n<p>Their unemployment rate estimate remained unchanged at 4.5%. In further evidence that the resumption of business activity has helped get people back to work, the government's latest initial jobless claims total is expected to drop to a new pandemic low of 360,000 for last week. </p>\n<p>The report is issued at 8:30 a.m. ET Thursday. Two weeks ago, new filings for unemployment benefits went below 400,000 for the first time since March 2020.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>CureVac(CVAC)</b> – CureVac shares plunged 46.2% in the premarket after the German drugmaker reported disappointing results from a study of its experimental Covid-19 vaccine. The treatment was 47% effective in a clinical trial, compared to more than 90% for other mRNA-based vaccines fromModerna(MRNA) andPfizer(PFE).</p>\n<p><b>Novavax(NVAX),BioNTech(BNTX)</b> – On the heels of the CureVac news, Novavax added 3.4% in the premarket while BioNTech rose 2.6%. BioNTech's Covid vaccine – developed in partnership with Pfizer – is already approved for use in the US, while Novavax reported 90% efficacy for its vaccine in a recent study.</p>\n<p><b>The Honest Company(HNST)</b> – The household products maker reported a wider-than-expected loss in its first quarter as a public company, although revenue was better than analysts had anticipated. Sales got a boost from pandemic-induced demand for sanitizing products. The stock tumbled 8.3% in premarket trading.</p>\n<p><b>Tenet Healthcare(THC)</b> – The hospital operator's shares jumped 3.5% in the premarket, after it announced the sale of five hospitals and associated physician practices in Florida to Steward Health Care for about $1.1 billion.</p>\n<p><b>Lennar(LEN)</b> – Lennar earned $2.65 per share for its latest quarter, beating the $2.36 a share consensus estimate. Revenue topped forecasts as well. The home builder is dealing with higher input costs and a labor shortage, but the lack of homes for sale in the U.S. helped push prices higher and expand Lennar's profit margins significantly over a year earlier.</p>\n<p><b>Dell Technologies(DELL)</b> – Dell was chosen byDish Network(DISH) to build key parts of the 5G network the satellite TV operator is building in the United States. Dish will launch 5G service in Las Vegas later this year and plans to cover 70% of the U.S. with its network by mid-2023.</p>\n<p><b>Fisker(FSR)</b> – Fisker shares added 2.8% in the premarket after the electric vehicle maker signed a long-term manufacturing agreement withMagna International(MGA). Magna will build the Fisker Ocean electric SUV starting in November 2022.</p>\n<p><b>Aon(AON)</b>,Willis Towers Watson(WLTW) – The U.S. Justice Department sued to block insurance company Aon's deal to buy consulting firm Willis Towers Watson for $35 billion. The department said the combinationcould eliminate competitionin several different markets. Aon and Willis Towers said the move showed a lack of understanding of their businesses, clients and the markets in which they operate.</p>\n<p><b>Akamai Technologies(AKAM)</b> – A variety of financial institutions, governments and airlines experienced brief website outages early Thursday. Some of the outages were linked to a failure at web services company Akamai Technologies, according to people familiar with the matter who spoke to Bloomberg. Akamai said it was aware of the issue and was working to restore service as soon as possible. Shares fell 1.5% in premarket trading.</p>\n<p><b>O'Reilly Automotive(ORLY)</b> – The auto parts retailer struck a new $1.8 billion revolving credit agreement with a group of banks led byJPMorgan Chase(JPM).</p>\n<p><b>Jack In The Box(JACK)</b> – The restaurant chain was rated \"outperform\" in new coverage at RBC Capital, which noted the stock's discounted valuation compared to its peers as well as upbeat prospects for new restaurant growth.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-17 20:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Technology stocks were set to lead Wall Street lower on Thursday after the Federal Reserve signaled it could start tapering its massive stimulus earlier than expected, piling pressure on a sector that is seen as vulnerable to higher interest rates.</p>\n<p>At 8:05 a.m. ET, Dow E-minis were down 61 points, or 0.18%, S&amp;P 500 E-minis were down 9.5 points, or 0.23% and Nasdaq 100 E-minis fell 52.75 points, or 0.38%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5c87220b14c23fa1ef2d424bd7883caf\" tg-width=\"584\" tg-height=\"215\"><span>*Source From Tiger Trade, EST 08:05</span></p>\n<p>Powell said progress toward the Fed's dual employment and inflation goals were happening somewhat faster than expected. Central bankers raised their GDP expectations for this year to 7% from 6.5% previously. </p>\n<p>Their unemployment rate estimate remained unchanged at 4.5%. In further evidence that the resumption of business activity has helped get people back to work, the government's latest initial jobless claims total is expected to drop to a new pandemic low of 360,000 for last week. </p>\n<p>The report is issued at 8:30 a.m. ET Thursday. Two weeks ago, new filings for unemployment benefits went below 400,000 for the first time since March 2020.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>CureVac(CVAC)</b> – CureVac shares plunged 46.2% in the premarket after the German drugmaker reported disappointing results from a study of its experimental Covid-19 vaccine. The treatment was 47% effective in a clinical trial, compared to more than 90% for other mRNA-based vaccines fromModerna(MRNA) andPfizer(PFE).</p>\n<p><b>Novavax(NVAX),BioNTech(BNTX)</b> – On the heels of the CureVac news, Novavax added 3.4% in the premarket while BioNTech rose 2.6%. BioNTech's Covid vaccine – developed in partnership with Pfizer – is already approved for use in the US, while Novavax reported 90% efficacy for its vaccine in a recent study.</p>\n<p><b>The Honest Company(HNST)</b> – The household products maker reported a wider-than-expected loss in its first quarter as a public company, although revenue was better than analysts had anticipated. Sales got a boost from pandemic-induced demand for sanitizing products. The stock tumbled 8.3% in premarket trading.</p>\n<p><b>Tenet Healthcare(THC)</b> – The hospital operator's shares jumped 3.5% in the premarket, after it announced the sale of five hospitals and associated physician practices in Florida to Steward Health Care for about $1.1 billion.</p>\n<p><b>Lennar(LEN)</b> – Lennar earned $2.65 per share for its latest quarter, beating the $2.36 a share consensus estimate. Revenue topped forecasts as well. The home builder is dealing with higher input costs and a labor shortage, but the lack of homes for sale in the U.S. helped push prices higher and expand Lennar's profit margins significantly over a year earlier.</p>\n<p><b>Dell Technologies(DELL)</b> – Dell was chosen byDish Network(DISH) to build key parts of the 5G network the satellite TV operator is building in the United States. Dish will launch 5G service in Las Vegas later this year and plans to cover 70% of the U.S. with its network by mid-2023.</p>\n<p><b>Fisker(FSR)</b> – Fisker shares added 2.8% in the premarket after the electric vehicle maker signed a long-term manufacturing agreement withMagna International(MGA). Magna will build the Fisker Ocean electric SUV starting in November 2022.</p>\n<p><b>Aon(AON)</b>,Willis Towers Watson(WLTW) – The U.S. Justice Department sued to block insurance company Aon's deal to buy consulting firm Willis Towers Watson for $35 billion. The department said the combinationcould eliminate competitionin several different markets. Aon and Willis Towers said the move showed a lack of understanding of their businesses, clients and the markets in which they operate.</p>\n<p><b>Akamai Technologies(AKAM)</b> – A variety of financial institutions, governments and airlines experienced brief website outages early Thursday. Some of the outages were linked to a failure at web services company Akamai Technologies, according to people familiar with the matter who spoke to Bloomberg. Akamai said it was aware of the issue and was working to restore service as soon as possible. Shares fell 1.5% in premarket trading.</p>\n<p><b>O'Reilly Automotive(ORLY)</b> – The auto parts retailer struck a new $1.8 billion revolving credit agreement with a group of banks led byJPMorgan Chase(JPM).</p>\n<p><b>Jack In The Box(JACK)</b> – The restaurant chain was rated \"outperform\" in new coverage at RBC Capital, which noted the stock's discounted valuation compared to its peers as well as upbeat prospects for new restaurant growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185082331","content_text":"Technology stocks were set to lead Wall Street lower on Thursday after the Federal Reserve signaled it could start tapering its massive stimulus earlier than expected, piling pressure on a sector that is seen as vulnerable to higher interest rates.\nAt 8:05 a.m. ET, Dow E-minis were down 61 points, or 0.18%, S&P 500 E-minis were down 9.5 points, or 0.23% and Nasdaq 100 E-minis fell 52.75 points, or 0.38%.\n*Source From Tiger Trade, EST 08:05\nPowell said progress toward the Fed's dual employment and inflation goals were happening somewhat faster than expected. Central bankers raised their GDP expectations for this year to 7% from 6.5% previously. \nTheir unemployment rate estimate remained unchanged at 4.5%. In further evidence that the resumption of business activity has helped get people back to work, the government's latest initial jobless claims total is expected to drop to a new pandemic low of 360,000 for last week. \nThe report is issued at 8:30 a.m. ET Thursday. Two weeks ago, new filings for unemployment benefits went below 400,000 for the first time since March 2020.\nStocks making the biggest moves in the premarket:\nCureVac(CVAC) – CureVac shares plunged 46.2% in the premarket after the German drugmaker reported disappointing results from a study of its experimental Covid-19 vaccine. The treatment was 47% effective in a clinical trial, compared to more than 90% for other mRNA-based vaccines fromModerna(MRNA) andPfizer(PFE).\nNovavax(NVAX),BioNTech(BNTX) – On the heels of the CureVac news, Novavax added 3.4% in the premarket while BioNTech rose 2.6%. BioNTech's Covid vaccine – developed in partnership with Pfizer – is already approved for use in the US, while Novavax reported 90% efficacy for its vaccine in a recent study.\nThe Honest Company(HNST) – The household products maker reported a wider-than-expected loss in its first quarter as a public company, although revenue was better than analysts had anticipated. Sales got a boost from pandemic-induced demand for sanitizing products. The stock tumbled 8.3% in premarket trading.\nTenet Healthcare(THC) – The hospital operator's shares jumped 3.5% in the premarket, after it announced the sale of five hospitals and associated physician practices in Florida to Steward Health Care for about $1.1 billion.\nLennar(LEN) – Lennar earned $2.65 per share for its latest quarter, beating the $2.36 a share consensus estimate. Revenue topped forecasts as well. The home builder is dealing with higher input costs and a labor shortage, but the lack of homes for sale in the U.S. helped push prices higher and expand Lennar's profit margins significantly over a year earlier.\nDell Technologies(DELL) – Dell was chosen byDish Network(DISH) to build key parts of the 5G network the satellite TV operator is building in the United States. Dish will launch 5G service in Las Vegas later this year and plans to cover 70% of the U.S. with its network by mid-2023.\nFisker(FSR) – Fisker shares added 2.8% in the premarket after the electric vehicle maker signed a long-term manufacturing agreement withMagna International(MGA). Magna will build the Fisker Ocean electric SUV starting in November 2022.\nAon(AON),Willis Towers Watson(WLTW) – The U.S. Justice Department sued to block insurance company Aon's deal to buy consulting firm Willis Towers Watson for $35 billion. The department said the combinationcould eliminate competitionin several different markets. Aon and Willis Towers said the move showed a lack of understanding of their businesses, clients and the markets in which they operate.\nAkamai Technologies(AKAM) – A variety of financial institutions, governments and airlines experienced brief website outages early Thursday. Some of the outages were linked to a failure at web services company Akamai Technologies, according to people familiar with the matter who spoke to Bloomberg. Akamai said it was aware of the issue and was working to restore service as soon as possible. Shares fell 1.5% in premarket trading.\nO'Reilly Automotive(ORLY) – The auto parts retailer struck a new $1.8 billion revolving credit agreement with a group of banks led byJPMorgan Chase(JPM).\nJack In The Box(JACK) – The restaurant chain was rated \"outperform\" in new coverage at RBC Capital, which noted the stock's discounted valuation compared to its peers as well as upbeat prospects for new restaurant growth.","news_type":1},"isVote":1,"tweetType":1,"viewCount":141,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161462685,"gmtCreate":1623938527347,"gmtModify":1634025603966,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/161462685","repostId":"1114861992","repostType":4,"repost":{"id":"1114861992","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623936627,"share":"https://www.laohu8.com/m/news/1114861992?lang=&edition=full","pubTime":"2021-06-17 21:30","market":"us","language":"en","title":"Stocks are flat after post-Fed decision sell-off","url":"https://stock-news.laohu8.com/highlight/detail?id=1114861992","media":"Tiger Newspress","summary":"Stocks were flat on Thursday, a day after the Federal Reserve's rate outlook sparked a sell-off.\nThe","content":"<p>Stocks were flat on Thursday, a day after the Federal Reserve's rate outlook sparked a sell-off.</p>\n<p>The Dow Jones Industrial Average dropped 5 points. The S&amp;P 500 was flat and Nasdaq Composite fell 0.15%.</p>\n<p>The closely-watch Federal Reserve meeting Wednesday spurred a sell-off in equities after the central bankmoved up its timeline for rate hikes, seeing two increases in 2023. The Fed also hiked its inflation hitting 3.4% this year, a percentage point higher than the FOMC's forecast in March.</p>\n<p>Materials stocks were set to drop on Thursday as higher rates may further take the air out of a big commodities rally in 2021. China isalso cracking down on the commodities surgeto ease inflation fears.Freeport-McMoRanled materials stocks lower in premarket trading, down 2%. Copper futures were off by 2%.</p>\n<p>Wells FargoandCitigroupwere higher in premarket trading on hopes higher rates will boost profits for banks. Meanwhile, some once-hot tech stocks were lower in premarket trading withZoom VideoandTesladown by about 1%.</p>\n<p>Hedge fund legend&nbsp;David Tepper&nbsp;told CNBC's Scott Wapnerthat the Fed did a good job on Wednesday and that \"the stock market is still fine for now,\" Tepper said. The S&amp;P 500 is less than 1% from an all-time high.</p>\n<p>On Wednesday, the Dow lost about 265 points and the S&amp;P 500 edged 0.5% lower. The Nasdaq Composite dipped 0.2%.</p>\n<p>Markets rallied off their intraday lows Wednesday after Fed Chair Jerome Powell said projections for future rate increases should be \"taken with a big grain of salt\" and reiterated that he believes that inflation is transitory. Powell also did not issue guidance on when the central bank will begin tapering its bond-buying program.</p>\n<p>\"You can think of this meeting that we had as the 'talking about talking about' meeting, if you'd like,\" Powell said when asked about tapering. \"I now suggest that we retire that term, which has served its purpose.\"</p>\n<p>The Fed chair said the central bank will continue to monitor the economic recovery and will provide \"advanced notice\" before announcing any updates regarding tapering.</p>\n<p>The Labor Department reported that initial jobless claimsrose last week to 412,000, an improvement from the previous week's 375,000, but above Dow Jones expectations of 360,000.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks are flat after post-Fed decision sell-off</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks are flat after post-Fed decision sell-off\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-17 21:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stocks were flat on Thursday, a day after the Federal Reserve's rate outlook sparked a sell-off.</p>\n<p>The Dow Jones Industrial Average dropped 5 points. The S&amp;P 500 was flat and Nasdaq Composite fell 0.15%.</p>\n<p>The closely-watch Federal Reserve meeting Wednesday spurred a sell-off in equities after the central bankmoved up its timeline for rate hikes, seeing two increases in 2023. The Fed also hiked its inflation hitting 3.4% this year, a percentage point higher than the FOMC's forecast in March.</p>\n<p>Materials stocks were set to drop on Thursday as higher rates may further take the air out of a big commodities rally in 2021. China isalso cracking down on the commodities surgeto ease inflation fears.Freeport-McMoRanled materials stocks lower in premarket trading, down 2%. Copper futures were off by 2%.</p>\n<p>Wells FargoandCitigroupwere higher in premarket trading on hopes higher rates will boost profits for banks. Meanwhile, some once-hot tech stocks were lower in premarket trading withZoom VideoandTesladown by about 1%.</p>\n<p>Hedge fund legend&nbsp;David Tepper&nbsp;told CNBC's Scott Wapnerthat the Fed did a good job on Wednesday and that \"the stock market is still fine for now,\" Tepper said. The S&amp;P 500 is less than 1% from an all-time high.</p>\n<p>On Wednesday, the Dow lost about 265 points and the S&amp;P 500 edged 0.5% lower. The Nasdaq Composite dipped 0.2%.</p>\n<p>Markets rallied off their intraday lows Wednesday after Fed Chair Jerome Powell said projections for future rate increases should be \"taken with a big grain of salt\" and reiterated that he believes that inflation is transitory. Powell also did not issue guidance on when the central bank will begin tapering its bond-buying program.</p>\n<p>\"You can think of this meeting that we had as the 'talking about talking about' meeting, if you'd like,\" Powell said when asked about tapering. \"I now suggest that we retire that term, which has served its purpose.\"</p>\n<p>The Fed chair said the central bank will continue to monitor the economic recovery and will provide \"advanced notice\" before announcing any updates regarding tapering.</p>\n<p>The Labor Department reported that initial jobless claimsrose last week to 412,000, an improvement from the previous week's 375,000, but above Dow Jones expectations of 360,000.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114861992","content_text":"Stocks were flat on Thursday, a day after the Federal Reserve's rate outlook sparked a sell-off.\nThe Dow Jones Industrial Average dropped 5 points. The S&P 500 was flat and Nasdaq Composite fell 0.15%.\nThe closely-watch Federal Reserve meeting Wednesday spurred a sell-off in equities after the central bankmoved up its timeline for rate hikes, seeing two increases in 2023. The Fed also hiked its inflation hitting 3.4% this year, a percentage point higher than the FOMC's forecast in March.\nMaterials stocks were set to drop on Thursday as higher rates may further take the air out of a big commodities rally in 2021. China isalso cracking down on the commodities surgeto ease inflation fears.Freeport-McMoRanled materials stocks lower in premarket trading, down 2%. Copper futures were off by 2%.\nWells FargoandCitigroupwere higher in premarket trading on hopes higher rates will boost profits for banks. Meanwhile, some once-hot tech stocks were lower in premarket trading withZoom VideoandTesladown by about 1%.\nHedge fund legend David Tepper told CNBC's Scott Wapnerthat the Fed did a good job on Wednesday and that \"the stock market is still fine for now,\" Tepper said. The S&P 500 is less than 1% from an all-time high.\nOn Wednesday, the Dow lost about 265 points and the S&P 500 edged 0.5% lower. The Nasdaq Composite dipped 0.2%.\nMarkets rallied off their intraday lows Wednesday after Fed Chair Jerome Powell said projections for future rate increases should be \"taken with a big grain of salt\" and reiterated that he believes that inflation is transitory. Powell also did not issue guidance on when the central bank will begin tapering its bond-buying program.\n\"You can think of this meeting that we had as the 'talking about talking about' meeting, if you'd like,\" Powell said when asked about tapering. \"I now suggest that we retire that term, which has served its purpose.\"\nThe Fed chair said the central bank will continue to monitor the economic recovery and will provide \"advanced notice\" before announcing any updates regarding tapering.\nThe Labor Department reported that initial jobless claimsrose last week to 412,000, an improvement from the previous week's 375,000, but above Dow Jones expectations of 360,000.","news_type":1},"isVote":1,"tweetType":1,"viewCount":174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":142822709,"gmtCreate":1626141928501,"gmtModify":1633929709721,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/142822709","repostId":"1175534160","repostType":4,"isVote":1,"tweetType":1,"viewCount":684,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120449218,"gmtCreate":1624334394634,"gmtModify":1634007615116,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/120449218","repostId":"1191349655","repostType":4,"isVote":1,"tweetType":1,"viewCount":542,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167677108,"gmtCreate":1624268018504,"gmtModify":1634008661767,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/167677108","repostId":"1184501396","repostType":4,"repost":{"id":"1184501396","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624267024,"share":"https://www.laohu8.com/m/news/1184501396?lang=&edition=full","pubTime":"2021-06-21 17:17","market":"us","language":"en","title":"Orphazyme rose more than 6% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1184501396","media":"Tiger Newspress","summary":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a c","content":"<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p>\n<p><img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p>\n<p><b>So what</b></p>\n<p>The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p>\n<p>Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p>\n<p>Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p>\n<p><b>Now what</b></p>\n<p>According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p>\n<p>Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p>\n<p>Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme rose more than 6% in premarket trading </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme rose more than 6% in premarket trading \n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-21 17:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p>\n<p><img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p>\n<p><b>So what</b></p>\n<p>The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p>\n<p>Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p>\n<p>Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p>\n<p><b>Now what</b></p>\n<p>According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p>\n<p>Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p>\n<p>Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p>\n<p></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184501396","content_text":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last Friday.\nSo what\nThe FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.\nInstead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.\nMany institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.\nNow what\nAccording to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.\nSome shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.\nDespite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.","news_type":1},"isVote":1,"tweetType":1,"viewCount":565,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":165091616,"gmtCreate":1624079232035,"gmtModify":1634010936496,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165091616","repostId":"2144034771","repostType":4,"isVote":1,"tweetType":1,"viewCount":641,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166480199,"gmtCreate":1624022514011,"gmtModify":1634023995857,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"[Doubt]&nbsp;","listText":"[Doubt]&nbsp;","text":"[Doubt]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/166480199","repostId":"1164089282","repostType":4,"isVote":1,"tweetType":1,"viewCount":572,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168462546,"gmtCreate":1623981233985,"gmtModify":1634024788926,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168462546","repostId":"2144374909","repostType":4,"isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168462335,"gmtCreate":1623981219127,"gmtModify":1634024789411,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"[Strong]&nbsp;","listText":"[Strong]&nbsp;","text":"[Strong]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168462335","repostId":"2144490227","repostType":4,"isVote":1,"tweetType":1,"viewCount":343,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168528788,"gmtCreate":1623979040844,"gmtModify":1634024864907,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"[Smile]&nbsp;[Smile]&nbsp;","listText":"[Smile]&nbsp;[Smile]&nbsp;","text":"[Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168528788","repostId":"2144742524","repostType":4,"repost":{"id":"2144742524","kind":"highlight","weMediaInfo":{"introduction":"The leading daily newsletter for the latest financial and business news. 33Yrs Helping Stock Investors with Investing Insights, Tools, News & More.","home_visible":0,"media_name":"Investors","id":"1085713068","head_image":"https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c"},"pubTimestamp":1623942517,"share":"https://www.laohu8.com/m/news/2144742524?lang=&edition=full","pubTime":"2021-06-17 23:08","market":"us","language":"en","title":"Ford Lifts Profit Guidance While F-150 Lightning, New Vehicles See Strong Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2144742524","media":"Investors","summary":"Ford joined GM with upbeat earnings guidance and sees strong reservations for critical new vehicles including its first electric truck.","content":"<p><b>Ford</b> joined <b>General Motors</b> with upbeat earnings guidance and sees strong reservations for critical new vehicles including its first electric truck. Ford stock rose.</p>\n<p>The No. 2 U.S. auto giant said Thursday that it expects adjusted pretax earnings for the second quarter to surpass its own expectations and be \"significantly better\" than a year ago.</p>\n<p>That's despite the semiconductor shortage, which Ford said April 28 would halve its planned Q2 production and reduce full-year adjusted EBIT to $5.5 billion-$6.5 billion.</p>\n<p>Ford did not offer specific Q2 guidance on April 28 or Thursday. It will report for Q2 and offer outlook for the rest of the year July 28.</p>\n<p>On Wednesday, GM forecast adjusted earnings before taxes of $8.5 billion-$9.5 billion in the first half of 2021, up from an earlier view for $5.5 billion, due to strong demand for its SUVs and trucks. GM remains cautious for the full year.</p>\n<p>Also Thursday, Ford touted 100,000 reservations for the F-150 Lightning, its first all-electric pickup truck and <b>Tesla</b> Cybertruck rival. That's up from 20,000 reported May 20 after a launch event, and 70,000 on May 26.</p>\n<p>Meanwhile, its new compact Maverick truck has 36,000 reservations, just a week after unveiling. Ford also reported 20,000 reservations for the all-electric E-Transit commercial van and 190,000 for the new, full-size Bronco SUV.</p>\n<p>CEO Jim Farley will further address Q2 financial guidance at a Deutsche Bank auto industry conference Thursday afternoon.</p>\n<h2>Ford Stock</h2>\n<p>Shares rose 1.3% to 15.22 in Thursday's stock market. Ford stock, on the IBD Leaderboard, is extended from a cup-without-handle 13.72 buy point, cleared late May on its bold EV shift. GM stock eased 1% to 61.07 as it eyes a 63.54 cup-shaped buy point.</p>\n<p>On Wednesday, GM announced it will invest $35 billion to develop electric vehicles (EVs) and autonomous vehicles (AVs) through 2025. That's a 30% increase from its most recent forecast for $27 billion set last November, and a 75% increase from an initial forecast of $20 billion set in March 2020.</p>\n<p>By comparison, Ford in May announced $30 billion on EV- AV spending through 2025, up from a prior view for $22 billion.</p>\n<p>But Ford's investments include years prior to 2020, while GM's spending is for 2020 through 2025.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ford Lifts Profit Guidance While F-150 Lightning, New Vehicles See Strong Demand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFord Lifts Profit Guidance While F-150 Lightning, New Vehicles See Strong Demand\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Investors </p>\n<p class=\"h-time\">2021-06-17 23:08</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Ford</b> joined <b>General Motors</b> with upbeat earnings guidance and sees strong reservations for critical new vehicles including its first electric truck. Ford stock rose.</p>\n<p>The No. 2 U.S. auto giant said Thursday that it expects adjusted pretax earnings for the second quarter to surpass its own expectations and be \"significantly better\" than a year ago.</p>\n<p>That's despite the semiconductor shortage, which Ford said April 28 would halve its planned Q2 production and reduce full-year adjusted EBIT to $5.5 billion-$6.5 billion.</p>\n<p>Ford did not offer specific Q2 guidance on April 28 or Thursday. It will report for Q2 and offer outlook for the rest of the year July 28.</p>\n<p>On Wednesday, GM forecast adjusted earnings before taxes of $8.5 billion-$9.5 billion in the first half of 2021, up from an earlier view for $5.5 billion, due to strong demand for its SUVs and trucks. GM remains cautious for the full year.</p>\n<p>Also Thursday, Ford touted 100,000 reservations for the F-150 Lightning, its first all-electric pickup truck and <b>Tesla</b> Cybertruck rival. That's up from 20,000 reported May 20 after a launch event, and 70,000 on May 26.</p>\n<p>Meanwhile, its new compact Maverick truck has 36,000 reservations, just a week after unveiling. Ford also reported 20,000 reservations for the all-electric E-Transit commercial van and 190,000 for the new, full-size Bronco SUV.</p>\n<p>CEO Jim Farley will further address Q2 financial guidance at a Deutsche Bank auto industry conference Thursday afternoon.</p>\n<h2>Ford Stock</h2>\n<p>Shares rose 1.3% to 15.22 in Thursday's stock market. Ford stock, on the IBD Leaderboard, is extended from a cup-without-handle 13.72 buy point, cleared late May on its bold EV shift. GM stock eased 1% to 61.07 as it eyes a 63.54 cup-shaped buy point.</p>\n<p>On Wednesday, GM announced it will invest $35 billion to develop electric vehicles (EVs) and autonomous vehicles (AVs) through 2025. That's a 30% increase from its most recent forecast for $27 billion set last November, and a 75% increase from an initial forecast of $20 billion set in March 2020.</p>\n<p>By comparison, Ford in May announced $30 billion on EV- AV spending through 2025, up from a prior view for $22 billion.</p>\n<p>But Ford's investments include years prior to 2020, while GM's spending is for 2020 through 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"F":"福特汽车","NGD":"New Gold"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144742524","content_text":"Ford joined General Motors with upbeat earnings guidance and sees strong reservations for critical new vehicles including its first electric truck. Ford stock rose.\nThe No. 2 U.S. auto giant said Thursday that it expects adjusted pretax earnings for the second quarter to surpass its own expectations and be \"significantly better\" than a year ago.\nThat's despite the semiconductor shortage, which Ford said April 28 would halve its planned Q2 production and reduce full-year adjusted EBIT to $5.5 billion-$6.5 billion.\nFord did not offer specific Q2 guidance on April 28 or Thursday. It will report for Q2 and offer outlook for the rest of the year July 28.\nOn Wednesday, GM forecast adjusted earnings before taxes of $8.5 billion-$9.5 billion in the first half of 2021, up from an earlier view for $5.5 billion, due to strong demand for its SUVs and trucks. GM remains cautious for the full year.\nAlso Thursday, Ford touted 100,000 reservations for the F-150 Lightning, its first all-electric pickup truck and Tesla Cybertruck rival. That's up from 20,000 reported May 20 after a launch event, and 70,000 on May 26.\nMeanwhile, its new compact Maverick truck has 36,000 reservations, just a week after unveiling. Ford also reported 20,000 reservations for the all-electric E-Transit commercial van and 190,000 for the new, full-size Bronco SUV.\nCEO Jim Farley will further address Q2 financial guidance at a Deutsche Bank auto industry conference Thursday afternoon.\nFord Stock\nShares rose 1.3% to 15.22 in Thursday's stock market. Ford stock, on the IBD Leaderboard, is extended from a cup-without-handle 13.72 buy point, cleared late May on its bold EV shift. GM stock eased 1% to 61.07 as it eyes a 63.54 cup-shaped buy point.\nOn Wednesday, GM announced it will invest $35 billion to develop electric vehicles (EVs) and autonomous vehicles (AVs) through 2025. That's a 30% increase from its most recent forecast for $27 billion set last November, and a 75% increase from an initial forecast of $20 billion set in March 2020.\nBy comparison, Ford in May announced $30 billion on EV- AV spending through 2025, up from a prior view for $22 billion.\nBut Ford's investments include years prior to 2020, while GM's spending is for 2020 through 2025.","news_type":1},"isVote":1,"tweetType":1,"viewCount":482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161449749,"gmtCreate":1623939014481,"gmtModify":1634025585276,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/161449749","repostId":"1160003162","repostType":4,"isVote":1,"tweetType":1,"viewCount":261,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163078207,"gmtCreate":1623854787509,"gmtModify":1634026991388,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"Ohh","listText":"Ohh","text":"Ohh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163078207","repostId":"2143912677","repostType":4,"isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163044072,"gmtCreate":1623854642196,"gmtModify":1634026996227,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"👍🏻","listText":"👍🏻","text":"👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163044072","repostId":"1100499327","repostType":4,"isVote":1,"tweetType":1,"viewCount":89,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163046740,"gmtCreate":1623854582980,"gmtModify":1634026997643,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"Ohh","listText":"Ohh","text":"Ohh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163046740","repostId":"2143779143","repostType":4,"isVote":1,"tweetType":1,"viewCount":203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163041528,"gmtCreate":1623854535764,"gmtModify":1634026999082,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163041528","repostId":"2143791791","repostType":4,"isVote":1,"tweetType":1,"viewCount":105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163057679,"gmtCreate":1623854484891,"gmtModify":1634027001652,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163057679","repostId":"2143179907","repostType":4,"isVote":1,"tweetType":1,"viewCount":122,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163054537,"gmtCreate":1623854468429,"gmtModify":1634027002481,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163054537","repostId":"1175265723","repostType":4,"isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}